Novel Hydrolyzable Tannins from Terminalia
J ournal of Natural Products, 2001, Vol. 64, No. 3 299
precipitate was removed by filtration and the filtrate evapo-
rated to dryness. The residue was subjected to a polyamide
SC60 column (5 g, 0.1% TFA) followed by chromatography on
Si gel [10 g, CHCl3-MeOH-H2O (60:35:5)]. Final purification
was achieved by chromatography on NH2 phase (solid-phase
extraction cartridge Adsorbex, Merck) using CH3CN as eluant.
The resulting D-glucose (11 mg) was identified by TLC and
compounds (n ) 6, in three replicates for each concentration).
Bayluscid was used as positive control (LC100 5 µg/mL).
P iscicid a l Activity. Compound 1 was tested at 50 and 75
µg/mL (n ) 30, in three replicates for each concentration)
against O. mossambicus using the standard protocol according
to Balza.23
determination of its optical rotation, [R]25 +59 (c 0.5, H2O),
Cytotoxic Assa y. Compounds 1-8 were screened against
Hep G2 (human hepatocellular carcinoma), MCF-7/S24 (N.I.H.
human breast adenocarcinoma, pleural effusion), MDA-MB-
231 (human breast adenocarcinoma), and 5637 cells (human
primary bladder carcinoma) using the method according to
Setzer.25
D
in comparison with an authentic sample (Merck).
Meth yla tion of 1. A mixture of 1 (500 mg), dimethyl sulfate
(2 mL), and anhydrous K2CO3 (2.8 g) in dry acetone (25 mL)
was heated under reflux for 4 h. After cooling, the precipitate
was removed by filtration. The resulting filtrate was acidified
with formic acid (pH 4) and concentrated under reduced
pressure. The residue was chromatographed on Si gel (35 g)
with petroleum ether-EtOAc (60:40 f 35:65) to afford the
hexadecamethyl ether 9 (279 mg) as a yellow crystalline
powder; positive ESIMS m/z 1309 [M + H]+, 1331 [M + Na]+,
Ack n ow led gm en t. We thank Norbert Nieth, Organisch
Chemisches Institut, Universita¨t Heidelberg, for recording the
HRFAB MS spectra.
1
1347 [M + K]+; H NMR (acetone-d6, 500 MHz) δ 7.71, 7.02
(2H in total, each s, aromatic H), 6.85, 6.82, 6.80, 6.79, 6.77,
6.67 (3H in total, each s, aromatic H), 4.30, 4.29, 4.00, 3.98,
3.94, 3.93, 3.89, 3.88 (×2), 3.87, 3.86, 3.84, 3.83, 3.82, 3.79,
3.78, 3.77 (×2), 3.73, 3.71, 3.70, 3.66, 3.65, 3.61, 3.60, 3.42,
3.32 (each s, total 16 CH3), 5.54 (t, J ) 9.5 Hz), 5.40 (m), 5.04
(dd, J ) 3.7, 9.7 Hz), 4.99 (d, J ) 3.7 Hz), 4.89 (t, J ) 9.8 Hz),
4.81 (m), 4.60 (dd, J ) 9.0, 12.0 Hz), 4.59 (dd, J ) 8.8, 12.0
Hz), 3.02 (bd, J ) 12.0 Hz), 3.00 (bd, J ) 12.0 Hz) (12H in
total, R/â sugar protons).
Su p p or tin g In for m a tion Ava ila ble: Structures of 1-8, part of
the GHMBC spectrum of 1, derivatization and degradation scheme of
1 and CD spectrum of 11. This material is available free of charge via
the Internet at http://pubs.acs.org.
Refer en ces a n d Notes
(1) von Maydell, H.-J . Trees and Shrubs of the Sahel; Verlag J oseph
Margraf: Weikersheim, 1990; pp 63-76 and 393.
(2) le Grand, A.; Wondergem, P. A.; Verpoorte, R.; Pousset, J . L. J .
Ethnopharmacol. 1988, 22, 25-31.
(3) Silva, O.; Ferreira, E.; Vaz Pato, M.; Gomes, E. Int. J . Pharmacogn.
1997, 35, 323-325.
(4) Sandberg, F.; Cronlund, A. J . Ethnopharmacol. 1982, 5, 187-204.
(5) Nongonierma, R.; Proliac, A.; Raynaud, J . Pharmazie 1987, 42, 871-
872.
Alk a lin e Meth a n olysis of 9. A solution of 9 (110 mg) in
dry methanol (50 mL) was treated dropwise with 5% sodium
methoxide to a final sodium methoxide concentration of 0.04%
in the reaction mixture. After 16 h at room temperature the
reaction mixture was neutralized with acetic acid, filtered, and
concentrated under reduced pressure. Chromatography of the
residue on Si gel (20 g) with petroleum ether-EtOAc (50:50
f 35:65) yielded the colorless oily dimethyl-(S)-hexamethoxy-
diphenoate (10) (17 mg) and nonamethylisoterchebulic acid
dimethyl ester (11) (14 mg) as a pale yellow powder. Compound
(6) Nongonierma, R.; Proliac, A.; Raynaud, J . Pharmazie 1988, 43, 293.
(7) Nongonierma, R.; Proliac, A.; Raynaud, J . Pharm. Acta Helv. 1990,
65 (8), 233-235.
(8) Noguetra, L.; de Almeida e Silva, L.; Correira Alves, A. Garcia Orta
1962, 10, 501-509; Chem. Abstr. 1964, 61, 12326.
(9) Silva, O.; Ferreira, E.; Romao, N.; Franco, S.; Porem, L.; Esmeraldo,
N.; Vaz Pato, M.; Gomes, E. T. In Book of Abstracts of the J oint
Meeting of the American Society of Pharmacognosy; GA, Phytochemi-
cal Society of Europe and AFERP: Amsterdam, 1999; abstract 429.
(10) Idemudia, O. G. Phytochemistry 1970, 9, 2401-2402.
(11) Conrad, J .; Vogler, B.; Klaiber, I.; Roos, G.; Walter, U.; Kraus, W.
Phytochemistry 1998, 48 (4), 647-650.
10: [R]25 -25° (c 1.69, CHCl3); CD (c 8.89 × 10-5, CH3CN) θ
D
(nm) -4.33 × 104 (248), +0.79 × 104 (308); H NMR (CDCl3,
1
300 MHz) δ 7.37 (2H, s, aromatic H), 3.94, 3.93, 3.60 (×2),
(each s, 8 CH3); positive ESIMS m/z 451 [M + H]+. Compound
11: [R]26D -33.9° (c 0.36, CHCl3); UV (CH3CN) λmax (log ꢀ) 214
(4.72), 254 (4.79), 370 (4.21) nm; CD (c 5.13 × 10-5, CH3CN) θ
(nm) -4.37 × 104 (242), +0.21 × 104 (257), -1.57 × 104 (270),
+1.33 × 104 (312); 1H and 13C NMR, see Table 3; positive
ESIMS m/z 815 [M + Na]+.
(12) Conrad, J .; Vogler, B.; Klaiber, I.; Reeb, S.; Guse, J .-H.; Roos, G.;
Kraus, W. Nat. Prod. Lett. 2000, 15, 35-43.
(13) J ossang, A.; Pousset, J . L.; Bodo, B. J . Nat. Prod. 1994, 57, 732-
737, and references therein.
4,6-O-(S)-Isoter ch ebu loyl-D-glu cose (2): tan amorphous
(14) Doig, A. J .; Williams, D. H.; Oelrichs, P. B.; Bacynskyi, L. J . Chem.
Soc., Perkin Trans. 1 1990, 2317-2321, and references therein.
(15) Tanaka, T.; Nonaka, G. I.; Nishioka, I. Chem. Pharm. Bull. 1986,
34, 1039-1049.
(16) Tanaka, T.; Nonaka, G. I.; Nishioka, I. Chem. Pharm. Bull. 1986,
34, 650-655.
(17) Tanaka, T.; Nonaka, G. I.; Nishioka, I. Chem. Pharm. Bull. 1986,
34, 656-663.
(18) Lin, T. C.; Nonaka, G. I.; Nishioka, I.; Ho, F. C. Chem. Pharm. Bull.
1990, 38, 3004-3008.
powder; mp (H2O) 212-215 °C (decomp); [R]25 -204° (c 0.5,
D
MeOH); UV (MeOH) λmax (log ꢀ) 220 (4.70), 262 (4.70), 378
(4.10) nm; CD (c 2.5 × 10-5, MeOH) θ (nm) -7.66 × 104 (218),
+5.83 × 104 (250), -0.80 × 104 (298), -1.20 × 104 (372); IR
(KBr) νmax 3413, 1723, 1608, 1521, 1459, 1435, 1362, 1178,
1
1059, 1017, 963, 881, 837, 771, 723 cm-1; H and 13C NMR,
see Tables 1 and 2; negative ESIMS and FABMS m/z 781 [M
- H]-; HRFABMS m/z 781.0554 [M - H]- (calcd for C34H21O22
requires 781.0516).
(19) Li, X.-C.; Elsohly, H. N.; Hufford, C. D.; Clark, A. M. Magn. Reson.
Chem. 1999, 37, 856-859.
An tim icr obia l Activity. Samples in serial dilutions [start-
ing concentration 1024 µg/mL, dilution factor 1/2n, two repli-
cates for each concentration] were tested in microdilution
assays according to established protocols20 using B. subtilis
and P. fluorescens as test organisms. The â-lactam antibiotic
Cefotaxim was used as a positive control (MIC 2 µg/mL).
An th elm in th ic Activity. The bioassay against C. elegans
was performed according to Simpkin and Coles.21 Compounds
were tested at 50 and 100 µg/mL (n ) 60, in two replicates for
each concentration), and biotests were evaluated by assessing
the increase in number of worms and their movement.11 The
anthelminthic Pyrantelembonate was used as a positive
control with strong activity (+++) at 50 µg/mL.
(20) (a) Vanden Berge, D. A.; Vlietinck, A. J . In Methods in Plant
Biochemistry; Dey, P. M., Harborne, J ., Eds.; Academic Press:
London, 1991; Vol. 6, pp 52-57. (b) ‘‘Arbeitsausschuss chemothera-
peutischer Untersuchungsmethoden‘‘ des Normenausschusses Mediz-
in (NAMed); DIN 58940, part 8. In Medizinische Mikrobiologie und
Immunologie; DIN pocket book 222; Beuth Verlag: Berlin, Ko¨ln, 1991.
(21) Simpkin, K. G.; Coles, G. C. J . Chem. Technol. Biotechnol. 1981, 31,
66-69.
(22) (a) Moser, D.; Klaiber, I.; Vogler, B.; Kraus, W. Pestic. Sci. 1999, 55,
336-339. (b) Nakanishi, K.; Kubo, I. Isr. J . Chem. 1977, 16, 28-31.
(c) Marston, K.; Hostettmann, K. In Methods in Plant Biochemistry;
Dey, P. M., Harborne, J ., Eds.; Academic Press: London, 1991; Vol.
6, pp 153-178.
(23) Balza, F.; Abranowski, Z.; Towers, G. H. N.; Wiryachitra, P. Phy-
tochemistry 1989, 23, 1827-1830.
(24) Osborne, C. K.; Hobbs, K.; Trent, J . M. Breast Cancer Res. Treat.
1987, 9 (2), 111-121.
(25) Setzer, M. C.; Setzer, W. N.; J ackes, B. R.; Gentry, G. A.; Moriarity,
D. M. Pharm. Biol. 2000, in press.
Mollu scicid a l Activity. Molluscicidal properties of the
compounds against B. glabrata were examined using a rapid
screening method.22 Samples were tested at 100 µg/mL (n )
6, in three replicates). In case of toxicity LC100 were determined
by serial dilutions (80, 60, 40, 20, 10 µg/mL) of the active
NP000506V